Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Activating Tgr5 may help treat hair loss and bone loss.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Exosome-based treatments may improve skin and hair issues, but more research is needed for safety and effectiveness.

Certain probiotics can help improve skin conditions like atopic dermatitis, but more research is needed.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Pu-erh tea reduces hair loss risk in offspring.

JAK inhibitors show promise for treating various skin diseases.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Hemp is a promising ingredient for skin products due to its healing and soothing properties.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Major depression disorder increases the risk of alopecia areata, and vice versa.

Testosterone's effects on COVID-19 are unclear and need more research.